Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03844672
Other study ID # 00081069
Secondary ID K01DA047433
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2019
Est. completion date November 9, 2023

Study information

Verified date April 2024
Source Medical University of South Carolina
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this project is to understand how different e-cigarettes influence their likeability and use among current smokers who try using e-cigarettes. Participants will receive an e-cigarette to sample over a three week period. During this time period they will complete daily electronic diaries and weekly lab visits. The results from this information will help understand how different types of e-cigarettes are likely to influence cigarette and e-cigarette use.


Recruitment information / eligibility

Status Completed
Enrollment 93
Est. completion date November 9, 2023
Est. primary completion date October 17, 2023
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion criteria include - adults who have been smoking daily - interested in using e-cigarettes - who have a smartphone that can receive text messages and access to the internet or has an e-mail account that they check daily Exclusion criteria include - minimal prior e-cigarette use - use of tobacco products other than cigarettes - current use of cessation medications - pregnant, trying to become pregnant, or breastfeeding, - recent history of cardiovascular distress in the last three months (e.g., arrhythmia, heart attack, stroke, uncontrolled hypertension), - household member currently enrolled in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Low Power
Participants will receive a low power e-cigarette to use for 3 weeks
High Power
Participants will receive a high power e-cigarette to use for 3 weeks
Low Concentration
Participants will receive a low concentration e-liquid to use for 3 weeks
High Concentration
Participants will receive a high concentration e-liquid to use for 3 weeks

Locations

Country Name City State
United States Medical University of South Carolina Charleston South Carolina

Sponsors (2)

Lead Sponsor Collaborator
Medical University of South Carolina National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean Cigarettes Per Day Participants complete daily electronic diaries reporting the number of cigarettes smoked each day on a continuous scale up to 3 weeks
Secondary Average Number of E-cigarette Puffing Episodes Participants complete daily electronic diaries reporting the number of e-cigarette puffing episodes each day on a continuous scale up to 3 Weeks
Secondary Number of Choices to Smoke Cigarette in Lab Setting Participants complete lab-based choice task at Week 3 visit in which they choose between smoking conventional cigarette and e-cigarette over 10 trials. Outcome is number of times each participant chooses to smoke conventional cigarette. Week 3
See also
  Status Clinical Trial Phase
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02649556 - A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 N/A
Completed NCT03901066 - Smoking Dependence and Periodontitis
Recruiting NCT05846841 - Personalized Tobacco Treatment in Primary Care (MOTIVATE) N/A
Completed NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Completed NCT03305978 - Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan. N/A
Completed NCT00000437 - Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Phase 4
Completed NCT06105424 - BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability N/A
Active, not recruiting NCT02752022 - Monitoring the Transition From Smoking to E-cigarettes
Completed NCT02901171 - The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation N/A
Completed NCT04340830 - The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants N/A
Completed NCT02912000 - TEACH: Technology Evaluation to Address Child Health N/A
Completed NCT03206619 - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed NCT02949648 - Electronic Cigarette Use and Quitting in Youth N/A
Completed NCT02945371 - Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life N/A
Completed NCT02246114 - Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women N/A
Completed NCT01898507 - Nicotine Metabolism and Low Nicotine Cigarettes N/A
Completed NCT02008292 - Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors N/A
Completed NCT01954407 - Young Adults' Responses to Anti-smoking Messages N/A